Wvc Ask The Expert Podcast

CYTOPOINT™ is a novel monoclonal antibody (mAb) therapy licensed by the USDA to help reduce clinical signs associated with atopic dermatitis in dogs. As a mAb, CYTOPOINT is specifically designed to target and neutralize cytokine IL-31, a key itch-inducing cytokine in canine atopic dermatitis. Did you enjoy this track? Listen & learn more at wvc.org/resources